Sydney Peters BS , Kristen Sportiello BS , Shreya Mandalapu BA , Ashlie Nguyen PsyD , Ryan Carrier MD , Carolyn Dickinson NP , Alex Paciorkowski MD , David Bearden MD
{"title":"ZC4H2 相关罕见疾病的基因型表型相关性和性别差异","authors":"Sydney Peters BS , Kristen Sportiello BS , Shreya Mandalapu BA , Ashlie Nguyen PsyD , Ryan Carrier MD , Carolyn Dickinson NP , Alex Paciorkowski MD , David Bearden MD","doi":"10.1016/j.pediatrneurol.2024.06.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><em>ZC4H2</em>-associated rare disorder (ZARD) is caused by pathogenic variations in the <em>ZC4H2</em> gene on the X chromosome. This gene codes for a zinc finger protein involved in neural development. ZARD is characterized by highly variable symptoms, potentially influenced by the sex of the individual.</p></div><div><h3>Methods</h3><p>The <em>ZC4H2</em>-Associated Rare Disorder Natural History Study is a prospective natural history study conducted among individuals with ZARD that consists of standardized interviews, developmental assessments, and neurological examinations conducted every six months for two years. In this article, we present data from baseline visits with 40 participants, the largest ZARD cohort studied thus far, focusing on genotype-phenotype correlations and sex differences. Fisher exact, maximum likelihood <em>χ</em><sup>2</sup>, and Mann-Whitney tests were utilized.</p></div><div><h3>Results</h3><p>Males tended to have maternally inherited <em>ZC4H2</em> pathogenic variations, whereas females tended to have <em>de novo</em> variations (<em>P</em> < 0.001). Female participants were more likely to have contractures at birth (<em>P</em> < 0.01), arthrogryposis multiplex congenita (<em>P</em> < 0.001), spasticity on examination (<em>P</em> < 0.1), and lower limb muscle atrophy (<em>P</em> < 0.05). Male participants were more likely to have seizures (<em>P</em> < 0.1), intermittent pain (<em>P</em> < 0.01), severe vision impairment (<em>P</em> < 0.05), dysphagia for solids (<em>P</em> < 0.01), and generalized muscle atrophy (<em>P</em> < 0.05).</p></div><div><h3>Conclusions</h3><p>Our study suggests there is significant overlap in severity and range of symptoms between males and females, although several symptoms are more common in one sex than the other. Further analysis is needed to better understand how pathogenic variation type affects phenotype.</p></div>","PeriodicalId":19956,"journal":{"name":"Pediatric neurology","volume":"158 ","pages":"Pages 100-112"},"PeriodicalIF":3.2000,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genotype-Phenotype Correlations and Sex Differences in ZC4H2-Associated Rare Disorder\",\"authors\":\"Sydney Peters BS , Kristen Sportiello BS , Shreya Mandalapu BA , Ashlie Nguyen PsyD , Ryan Carrier MD , Carolyn Dickinson NP , Alex Paciorkowski MD , David Bearden MD\",\"doi\":\"10.1016/j.pediatrneurol.2024.06.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p><em>ZC4H2</em>-associated rare disorder (ZARD) is caused by pathogenic variations in the <em>ZC4H2</em> gene on the X chromosome. This gene codes for a zinc finger protein involved in neural development. ZARD is characterized by highly variable symptoms, potentially influenced by the sex of the individual.</p></div><div><h3>Methods</h3><p>The <em>ZC4H2</em>-Associated Rare Disorder Natural History Study is a prospective natural history study conducted among individuals with ZARD that consists of standardized interviews, developmental assessments, and neurological examinations conducted every six months for two years. In this article, we present data from baseline visits with 40 participants, the largest ZARD cohort studied thus far, focusing on genotype-phenotype correlations and sex differences. Fisher exact, maximum likelihood <em>χ</em><sup>2</sup>, and Mann-Whitney tests were utilized.</p></div><div><h3>Results</h3><p>Males tended to have maternally inherited <em>ZC4H2</em> pathogenic variations, whereas females tended to have <em>de novo</em> variations (<em>P</em> < 0.001). Female participants were more likely to have contractures at birth (<em>P</em> < 0.01), arthrogryposis multiplex congenita (<em>P</em> < 0.001), spasticity on examination (<em>P</em> < 0.1), and lower limb muscle atrophy (<em>P</em> < 0.05). Male participants were more likely to have seizures (<em>P</em> < 0.1), intermittent pain (<em>P</em> < 0.01), severe vision impairment (<em>P</em> < 0.05), dysphagia for solids (<em>P</em> < 0.01), and generalized muscle atrophy (<em>P</em> < 0.05).</p></div><div><h3>Conclusions</h3><p>Our study suggests there is significant overlap in severity and range of symptoms between males and females, although several symptoms are more common in one sex than the other. Further analysis is needed to better understand how pathogenic variation type affects phenotype.</p></div>\",\"PeriodicalId\":19956,\"journal\":{\"name\":\"Pediatric neurology\",\"volume\":\"158 \",\"pages\":\"Pages 100-112\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0887899424002340\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric neurology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887899424002340","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Genotype-Phenotype Correlations and Sex Differences in ZC4H2-Associated Rare Disorder
Background
ZC4H2-associated rare disorder (ZARD) is caused by pathogenic variations in the ZC4H2 gene on the X chromosome. This gene codes for a zinc finger protein involved in neural development. ZARD is characterized by highly variable symptoms, potentially influenced by the sex of the individual.
Methods
The ZC4H2-Associated Rare Disorder Natural History Study is a prospective natural history study conducted among individuals with ZARD that consists of standardized interviews, developmental assessments, and neurological examinations conducted every six months for two years. In this article, we present data from baseline visits with 40 participants, the largest ZARD cohort studied thus far, focusing on genotype-phenotype correlations and sex differences. Fisher exact, maximum likelihood χ2, and Mann-Whitney tests were utilized.
Results
Males tended to have maternally inherited ZC4H2 pathogenic variations, whereas females tended to have de novo variations (P < 0.001). Female participants were more likely to have contractures at birth (P < 0.01), arthrogryposis multiplex congenita (P < 0.001), spasticity on examination (P < 0.1), and lower limb muscle atrophy (P < 0.05). Male participants were more likely to have seizures (P < 0.1), intermittent pain (P < 0.01), severe vision impairment (P < 0.05), dysphagia for solids (P < 0.01), and generalized muscle atrophy (P < 0.05).
Conclusions
Our study suggests there is significant overlap in severity and range of symptoms between males and females, although several symptoms are more common in one sex than the other. Further analysis is needed to better understand how pathogenic variation type affects phenotype.
期刊介绍:
Pediatric Neurology publishes timely peer-reviewed clinical and research articles covering all aspects of the developing nervous system.
Pediatric Neurology features up-to-the-minute publication of the latest advances in the diagnosis, management, and treatment of pediatric neurologic disorders. The journal''s editor, E. Steve Roach, in conjunction with the team of Associate Editors, heads an internationally recognized editorial board, ensuring the most authoritative and extensive coverage of the field. Among the topics covered are: epilepsy, mitochondrial diseases, congenital malformations, chromosomopathies, peripheral neuropathies, perinatal and childhood stroke, cerebral palsy, as well as other diseases affecting the developing nervous system.